```html

Xanthine Urolithiasis (Urinary Stone Formation)

What is Xanthine urolithiasis (urinary stone formation)?

Xanthine urolithiasis is a rare type of kidney or urinary‑tract stone that is composed primarily of the purine metabolite xanthine. Unlike the more common calcium‑oxalate or uric acid stones, xanthine stones form when the body cannot efficiently convert xanthine into the more soluble compound uric acid. The resulting supersaturation of xanthine in the urine leads to crystallisation and stone formation.

Most cases are inherited (autosomal recessive) and are termed xanthinuria. The condition may present in childhood or early adulthood, but milder forms can be discovered incidentally in adults during imaging for unrelated problems.

Sources:

• Mayo Clinic – Kidney stones
• NIH – Xanthinuria
• World Health Organization, Guidelines on Metabolic Disorders (2022)

Common Causes

The majority of xanthine stones develop because of an underlying metabolic defect, but several other factors can increase the risk. The most frequent causes include:

• Xanthinuria type I – deficiency of the enzyme xanthine oxidase (XDH) caused by mutations in the XDH gene.
• Xanthinuria type II – combined deficiency of xanthine oxidase and aldehyde oxidase due to mutations in the MOCOS gene.
• High‑purine diet – excessive intake of meat, fish, organ meat, and certain legumes can raise urinary xanthine.
• Low fluid intake – concentrated urine promotes crystallisation.
• Genetic consanguinity – increases the chance of inheriting recessive mutations.
• Renal tubular dysfunction – disorders that reduce tubular reabsorption of water and solutes.
• Medications that increase purine load – e.g., chemotherapy agents (6‑mercaptopurine, azathioprine) or high‑dose vitamin C (which can be metabolised to oxalate & indirectly raise purine turnover).
• Severe dehydration – seen in athletes, outdoor workers, or during febrile illness.
• Metabolic acidosis – shifts purine metabolism toward xanthine production.
• Rare overlapping metabolic disorders – such as hereditary hyperuricosuria that co‑exists with xanthinuria.

Associated Symptoms

Symptoms arise from stone formation, obstruction, or the underlying metabolic disorder. Commonly reported manifestations are:

• Flank or lower‑back pain that comes in waves (renal colic).
• Hematuria – visible (gross) or microscopic blood in the urine.
• Frequent urination or urgency, especially if a stone is lodged in the bladder or urethra.
• Painful urination (dysuria) when stones irritate the urethra or bladder neck.
• Recurrent urinary tract infections (UTIs) due to urine stasis.
• Kidney swelling (hydronephrosis) seen on imaging when a stone blocks the ureter.
• In children with severe disease, growth retardation may be noted because of chronic kidney involvement.

When to See a Doctor

Prompt evaluation is crucial to prevent permanent kidney damage. Seek medical attention if you experience any of the following:

• Sudden, severe flank pain lasting more than a few minutes.
• Blood in the urine that does not clear within 24 hours.
• Persistent burning or difficulty urinating.
• Fever ≥ 38 °C (100.4 °F) with chills – possible infection.
• Decreased urine output or a feeling of bladder fullness without relief.
• Recurrent stone episodes (more than two in a year).

Diagnosis

Diagnosis requires a combination of clinical assessment, laboratory testing, and imaging.

1. Medical History & Physical Exam

The clinician will ask about family history, dietary habits, fluid intake, prior stone events, and any medications that may affect purine metabolism.

2. Urine Studies

• 24‑hour urine collection – measures xanthine concentration, pH, volume, and other stone‑forming substances.
• Spot urine xanthine/uric acid ratio – elevated xanthine with low uric acid is classic for xanthinuria.
• Urine microscopy – looks for crystals; xanthine crystals appear as fine, colourless, rhomboid shapes.

3. Blood Tests

• Serum creatinine & eGFR – assess kidney function.
• Serum uric acid – typically low or normal in xanthinuria.
• Genetic testing – sequencing of XDH and MOCOS genes confirms inherited xanthinuria.

4. Imaging

• Non‑contrast helical CT scan – gold standard for detecting even tiny stones.
• Ultrasound – useful in children or pregnant patients; shows hydronephrosis and echogenic stones.
• Plain abdominal X‑ray (KUB) – limited sensitivity because xanthine stones are radiolucent.

5. Stone Analysis

If a stone is passed or removed, infrared spectroscopy or X‑ray diffraction confirms its composition as xanthine.

Treatment Options

Treatment aims to dissolve existing stones (when possible), alleviate symptoms, prevent new stones, and address the metabolic defect.

Medical Management

• Hydration – Drink >2.5 L of fluid daily (≈0.5 L per 10 kg body weight) to keep urine output >2 L/day and keep urine xanthine concentration low.
• Alkalinisation of urine – Sodium bicarbonate or potassium citrate can raise urine pH, slightly improving xanthine solubility.
• Low‑purine diet – Limit meat, fish, organ meats, legumes, and high‑fructose corn syrup.
• Allopurinol avoidance – Paradoxically, allopurinol reduces uric acid but can increase xanthine levels; it is contraindicated in xanthinuria.
• Pharmacologic inhibition of xanthine production – Currently no approved drugs; research is exploring enzyme‑replacement and gene‑therapy approaches.

Surgical / Procedural Interventions

• Extracorporeal shock‑wave lithotripsy (ESWL) – Effective for stones <2 cm that are not too dense.
• Ureteroscopic laser lithotripsy – Preferred for distal ureter stones.
• Percutaneous nephrolithotomy (PCNL) – Used for large (>2 cm) or staghorn‑type xanthine stones.
• Stent placement – Temporarily relieves obstruction while definitive stone removal is planned.

Supportive Care

• Pain control with NSAIDs (e.g., ibuprofen) or opioids if needed.
• Antibiotics for secondary urinary‑tract infection.

Prevention Tips

Because xanthine stones are largely driven by genetics, complete elimination is impossible, but recurrence can be markedly reduced by lifestyle measures.

• Maintain high fluid intake – Aim for urine that is pale yellow throughout the day.
• Adopt a low‑purine diet –
  • Limit red meat to ≤3 oz per serving, 2–3 times per week.
  • Avoid organ meats (liver, kidney, brain).
  • Choose plant‑based proteins such as tofu (moderately) and beans in limited amounts.
• Avoid vitamin C megadoses – >1 g/day can increase oxalate and indirectly raise purine turnover.
• Stay active but replace fluids – Sweat loss during exercise must be compensated with water or electrolyte drinks.
• Monitor urine pH – Aim for a pH of 6.0–6.5; use home test strips if recommended by your clinician.
• Regular follow‑up – 6–12 month 24‑hour urine studies to adjust fluid and diet plans.
• Genetic counseling – Families with confirmed xanthinuria benefit from counseling about inheritance risks.

Emergency Warning Signs

Key Take‑aways

• Xanthine urolithiasis is a rare, often inherited stone disease caused by impaired conversion of xanthine to uric acid.
• High fluid intake, a low‑purine diet, and urine alkalinisation are the cornerstones of prevention and non‑invasive treatment.
• When stones cause obstruction, pain, or infection, medical or surgical interventions such as ESWL, ureteroscopy, or PCNL are required.
• Early recognition of warning signs and regular metabolic monitoring can keep the condition under control and protect kidney function.

For personalized advice, discuss your symptoms and test results with a urologist or a metabolic specialist. The information above reflects current guidelines from reputable sources such as the Mayo Clinic, NIH, and WHO as of 2024.

```